ReP USP - Resultado da busca

Artigo de periodico-carta/editorial
Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: Where do we stand? Volume II (2022)
Malmegrim, Kelen Cristina Ribeiro ; Toubert, A.; Farge, D.; Rodrigues, Maria Carolina de Oliveira
Source: Frontiers in Immunology. Unidades: FCFRP, FMRP
Subjects: DOENÇAS AUTOIMUNES, TRANSPLANTE AUTÓLOGO, CÉLULAS-TRONCO, ESCLEROSE MÚLTIPLA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALMEGRIM, Kelen Cristina Ribeiro et al. Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: Where do we stand? Volume II. Frontiers in Immunology. Lausanne: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.3389/fimmu.2022.1038338. Acesso em: 28 abr. 2024. , 2022
APA
Malmegrim, K. C. R., Toubert, A., Farge, D., & Rodrigues, M. C. de O. (2022). Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: Where do we stand? Volume II. Frontiers in Immunology. Lausanne: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.3389/fimmu.2022.1038338
NLM
Malmegrim KCR, Toubert A, Farge D, Rodrigues MC de O. Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: Where do we stand? Volume II [Internet]. Frontiers in Immunology. 2022 ; 13 1-3.[citado 2024 abr. 28 ] Available from: https://doi.org/10.3389/fimmu.2022.1038338
Vancouver
Malmegrim KCR, Toubert A, Farge D, Rodrigues MC de O. Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: Where do we stand? Volume II [Internet]. Frontiers in Immunology. 2022 ; 13 1-3.[citado 2024 abr. 28 ] Available from: https://doi.org/10.3389/fimmu.2022.1038338
Artigo de periodico
Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients (2021)
Lima-Júnior, João R.; Arruda, Lucas C. M.; Gonçalves, Maynara Santana; Dias, Juliana B. E.; Moraes, Daniela A.; Covas, Dimas Tadeu; Simões, Belinda Pinto; Oliveira, Maria Carolina; Malmegrim, Kelen Cristina Ribeiro
Source: Rheumatology. Unidades: FMRP, FCFRP
Subjects: DOENÇAS AUTOIMUNES, TRANSPLANTE AUTÓLOGO, CÉLULAS-TRONCO, TRANSPLANTE DE ÓRGÃOS, INTERLEUCINAS, SISTEMA IMUNE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA-JÚNIOR, João R. et al. Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients. Rheumatology, v. 60, n. 12, p. 5538–5548, 2021Tradução . . Disponível em: https://doi.org/10.1093/rheumatology/keab257. Acesso em: 28 abr. 2024.
APA
Lima-Júnior, J. R., Arruda, L. C. M., Gonçalves, M. S., Dias, J. B. E., Moraes, D. A., Covas, D. T., et al. (2021). Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients. Rheumatology, 60( 12), 5538–5548. doi:10.1093/rheumatology/keab257
NLM
Lima-Júnior JR, Arruda LCM, Gonçalves MS, Dias JBE, Moraes DA, Covas DT, Simões BP, Oliveira MC, Malmegrim KCR. Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients [Internet]. Rheumatology. 2021 ; 60( 12): 5538–5548.[citado 2024 abr. 28 ] Available from: https://doi.org/10.1093/rheumatology/keab257
Vancouver
Lima-Júnior JR, Arruda LCM, Gonçalves MS, Dias JBE, Moraes DA, Covas DT, Simões BP, Oliveira MC, Malmegrim KCR. Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients [Internet]. Rheumatology. 2021 ; 60( 12): 5538–5548.[citado 2024 abr. 28 ] Available from: https://doi.org/10.1093/rheumatology/keab257
Artigo de periodico
Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms (2021)
Cominal, Juçara Gastaldi; Cacemiro, Maira da Costa ; Berzoti-Coelho, Maria Gabriela ; Pereira, Illy Enne Gomes ; Frantz, Fabiani Gai ; Souto, Elizabeth Xisto; Covas, Dimas Tadeu; Figueiredo-Pontes, Lorena Lobo de; Oliveira, Maria Carolina; Malmegrim, Kelen Cristina Ribeiro ; Castro, Fabíola Attié de
Source: Frontiers in Oncology. Unidades: FCFRP, FMRP
Subjects: NEOVASCULARIZAÇÃO PATOLÓGICA, MEDULA ÓSSEA, CITOCINAS, INFLAMAÇÃO, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COMINAL, Juçara Gastaldi et al. Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms. Frontiers in Oncology, v. 11, p. 1-12 , 2021Tradução . . Disponível em: https://doi.org/10.3389/fonc.2021.665037. Acesso em: 28 abr. 2024.
APA
Cominal, J. G., Cacemiro, M. da C., Berzoti-Coelho, M. G., Pereira, I. E. G., Frantz, F. G., Souto, E. X., et al. (2021). Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms. Frontiers in Oncology, 11, 1-12 . doi:10.3389/fonc.2021.665037
NLM
Cominal JG, Cacemiro M da C, Berzoti-Coelho MG, Pereira IEG, Frantz FG, Souto EX, Covas DT, Figueiredo-Pontes LL de, Oliveira MC, Malmegrim KCR, Castro FA de. Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms [Internet]. Frontiers in Oncology. 2021 ; 11 1-12 .[citado 2024 abr. 28 ] Available from: https://doi.org/10.3389/fonc.2021.665037
Vancouver
Cominal JG, Cacemiro M da C, Berzoti-Coelho MG, Pereira IEG, Frantz FG, Souto EX, Covas DT, Figueiredo-Pontes LL de, Oliveira MC, Malmegrim KCR, Castro FA de. Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms [Internet]. Frontiers in Oncology. 2021 ; 11 1-12 .[citado 2024 abr. 28 ] Available from: https://doi.org/10.3389/fonc.2021.665037
Artigo de periodico
Hypoxia priming improves in vitro angiogenic properties of umbilical cord derived-mesenchymal stromal cells expanded in stirred-tank bioreactor (2021)
Noronha, Nadia de Cássia; Mizukami, Amanda; Orellana, Maristela Delgado; Oliveira, Maria Carolina de; Covas, Dimas Tadeu; Swiech, Kamilla; Malmegrim, Kelen Cristina Ribeiro
Source: Biochemical Engineering Journal. Unidades: FMRP, FCFRP
Subjects: CÉLULAS ESTROMAIS, ANÓXIA, REATORES BIOQUÍMICOS, ADJUVANTES IMUNOLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NORONHA, Nadia de Cássia et al. Hypoxia priming improves in vitro angiogenic properties of umbilical cord derived-mesenchymal stromal cells expanded in stirred-tank bioreactor. Biochemical Engineering Journal, v. 168, p. 1-11, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bej.2021.107949. Acesso em: 28 abr. 2024.
APA
Noronha, N. de C., Mizukami, A., Orellana, M. D., Oliveira, M. C. de, Covas, D. T., Swiech, K., & Malmegrim, K. C. R. (2021). Hypoxia priming improves in vitro angiogenic properties of umbilical cord derived-mesenchymal stromal cells expanded in stirred-tank bioreactor. Biochemical Engineering Journal, 168, 1-11. doi:10.1016/j.bej.2021.107949
NLM
Noronha N de C, Mizukami A, Orellana MD, Oliveira MC de, Covas DT, Swiech K, Malmegrim KCR. Hypoxia priming improves in vitro angiogenic properties of umbilical cord derived-mesenchymal stromal cells expanded in stirred-tank bioreactor [Internet]. Biochemical Engineering Journal. 2021 ; 168 1-11.[citado 2024 abr. 28 ] Available from: https://doi.org/10.1016/j.bej.2021.107949
Vancouver
Noronha N de C, Mizukami A, Orellana MD, Oliveira MC de, Covas DT, Swiech K, Malmegrim KCR. Hypoxia priming improves in vitro angiogenic properties of umbilical cord derived-mesenchymal stromal cells expanded in stirred-tank bioreactor [Internet]. Biochemical Engineering Journal. 2021 ; 168 1-11.[citado 2024 abr. 28 ] Available from: https://doi.org/10.1016/j.bej.2021.107949
Monografia/livro-ed/org
Chimeric antigen receptor T Cells: development and production (2020)
Swiech, Kamilla (Editor) ; Malmegrim, Kelen Cristina Ribeiro (Editor) ; Picanço-Castro, Virgínia (Editor)
Unidades: FCFRP, FMRP
Subjects: IMUNOTERAPIA, ANTÍGENOS, BIOLOGIA MOLECULAR, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Chimeric antigen receptor T Cells: development and production. . New York: Humana Press. Disponível em: https://doi.org/10.1007/978-1-0716-0146-4. Acesso em: 28 abr. 2024. , 2020
APA
Chimeric antigen receptor T Cells: development and production. (2020). Chimeric antigen receptor T Cells: development and production. New York: Humana Press. doi:10.1007/978-1-0716-0146-4
NLM
Chimeric antigen receptor T Cells: development and production [Internet]. 2020 ;[citado 2024 abr. 28 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Vancouver
Chimeric antigen receptor T Cells: development and production [Internet]. 2020 ;[citado 2024 abr. 28 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Monografia/livro-ed/org
Chimeric antigen receptor T Cell: development and production (2020)
Swiech, Kamilla (Editor) ; Malmegrim, Kelen Cristina Ribeiro (Editor) ; Picanço-Castro, Virgínia (Editor)
Unidades: FCFRP, FMRP
Subjects: IMUNOTERAPIA, RECEPTORES DE ANTÍGENOS, ANTÍGENOS, LINHAGEM CELULAR, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Chimeric antigen receptor T Cell: development and production. . New York: Humana Press. Disponível em: https://doi.org/10.1007/978-1-0716-0146-4. Acesso em: 28 abr. 2024. , 2020
APA
Chimeric antigen receptor T Cell: development and production. (2020). Chimeric antigen receptor T Cell: development and production. New York: Humana Press. doi:10.1007/978-1-0716-0146-4
NLM
Chimeric antigen receptor T Cell: development and production [Internet]. 2020 ;[citado 2024 abr. 28 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Vancouver
Chimeric antigen receptor T Cell: development and production [Internet]. 2020 ;[citado 2024 abr. 28 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Parte de monografia/livro-apres/pref/posf
Immunotherapy is a treatment that boosts the body’s natural defenses to fight cancer. [Prefácio] (2020)
Swiech, Kamilla ; Malmegrim, Kelen Cristina Ribeiro ; Picanço-Castro, Virgínia
Source: Chimeric antigen receptor T Cell: development and production. Unidades: FCFRP, FMRP
Subjects: IMUNOTERAPIA, ANTÍGENOS, RECEPTORES DE ANTÍGENOS, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SWIECH, Kamilla e MALMEGRIM, Kelen Cristina Ribeiro e PICANÇO-CASTRO, Virgínia. Immunotherapy is a treatment that boosts the body’s natural defenses to fight cancer. [Prefácio]. Chimeric antigen receptor T Cell: development and production. New York: Humana Press. Disponível em: https://doi.org/10.1007/978-1-0716-0146-4. Acesso em: 28 abr. 2024. , 2020
APA
Swiech, K., Malmegrim, K. C. R., & Picanço-Castro, V. (2020). Immunotherapy is a treatment that boosts the body’s natural defenses to fight cancer. [Prefácio]. Chimeric antigen receptor T Cell: development and production. New York: Humana Press. doi:10.1007/978-1-0716-0146-4
NLM
Swiech K, Malmegrim KCR, Picanço-Castro V. Immunotherapy is a treatment that boosts the body’s natural defenses to fight cancer. [Prefácio] [Internet]. Chimeric antigen receptor T Cell: development and production. 2020 ;274 .[citado 2024 abr. 28 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Vancouver
Swiech K, Malmegrim KCR, Picanço-Castro V. Immunotherapy is a treatment that boosts the body’s natural defenses to fight cancer. [Prefácio] [Internet]. Chimeric antigen receptor T Cell: development and production. 2020 ;274 .[citado 2024 abr. 28 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Parte de monografia/livro
Immunophenotypic analysis of CAR-T cells (2020)
Azevedo, Júlia Teixeira Cottas de ; Mizukami, Amanda ; Moço, Pablo Diego ; Malmegrim, Kelen Cristina Ribeiro
Source: Chimeric antigen receptor T Cell: development and production. Unidades: FCFRP, FMRP
Subjects: RECEPTORES DE ANTÍGENOS, ANTÍGENOS, IMUNOTERAPIA, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AZEVEDO, Júlia Teixeira Cottas de et al. Immunophenotypic analysis of CAR-T cells. Chimeric antigen receptor T Cell: development and production. Tradução . New York: Humana Press, 2020. p. 274 . Disponível em: https://doi.org/10.1007/978-1-0716-0146-4. Acesso em: 28 abr. 2024.
APA
Azevedo, J. T. C. de, Mizukami, A., Moço, P. D., & Malmegrim, K. C. R. (2020). Immunophenotypic analysis of CAR-T cells. In Chimeric antigen receptor T Cell: development and production (p. 274 ). New York: Humana Press. doi:10.1007/978-1-0716-0146-4
NLM
Azevedo JTC de, Mizukami A, Moço PD, Malmegrim KCR. Immunophenotypic analysis of CAR-T cells [Internet]. In: Chimeric antigen receptor T Cell: development and production. New York: Humana Press; 2020. p. 274 .[citado 2024 abr. 28 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Vancouver
Azevedo JTC de, Mizukami A, Moço PD, Malmegrim KCR. Immunophenotypic analysis of CAR-T cells [Internet]. In: Chimeric antigen receptor T Cell: development and production. New York: Humana Press; 2020. p. 274 .[citado 2024 abr. 28 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Tese (Doutorado)
Estudo dos mecanismos imunológicos do transplante autólogo de células-tronco hematopoéticas em pacientes com esclerose sistêmica (2017)
Arruda, Lucas Coelho Marlière; Rodrigues, Maria Carolina de Oliveira (Orientador); Malmegrim, Kelen Cristina Ribeiro (coorient)
Unidade: FMRP
Subjects: AUTOIMUNIDADE, TRANSPLANTE AUTÓLOGO, CÉLULAS-TRONCO, DOENÇAS AUTOIMUNES, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARRUDA, Lucas Coelho Marlière. Estudo dos mecanismos imunológicos do transplante autólogo de células-tronco hematopoéticas em pacientes com esclerose sistêmica. 2017. Tese (Doutorado) – Universidade de São Paulo, Ribeirão Preto, 2017. Disponível em: http://www.teses.usp.br/teses/disponiveis/17/17147/tde-04042018-144303/. Acesso em: 28 abr. 2024.
APA
Arruda, L. C. M. (2017). Estudo dos mecanismos imunológicos do transplante autólogo de células-tronco hematopoéticas em pacientes com esclerose sistêmica (Tese (Doutorado). Universidade de São Paulo, Ribeirão Preto. Recuperado de http://www.teses.usp.br/teses/disponiveis/17/17147/tde-04042018-144303/
NLM
Arruda LCM. Estudo dos mecanismos imunológicos do transplante autólogo de células-tronco hematopoéticas em pacientes com esclerose sistêmica [Internet]. 2017 ;[citado 2024 abr. 28 ] Available from: http://www.teses.usp.br/teses/disponiveis/17/17147/tde-04042018-144303/
Vancouver
Arruda LCM. Estudo dos mecanismos imunológicos do transplante autólogo de células-tronco hematopoéticas em pacientes com esclerose sistêmica [Internet]. 2017 ;[citado 2024 abr. 28 ] Available from: http://www.teses.usp.br/teses/disponiveis/17/17147/tde-04042018-144303/
Artigo de periodico
Microvascular complications in type 1 diabetes: a comparative analysis of patients treated with autologous nonmyeloablative hematopoietic stem-cell transplantation and conventional medical therapy (2017)
Saboia, Jaquellyne G. Penaforte; Montenegro, Renan M.; Couri, Carlos E.; Batista, Livia A.; Montenegro, Ana Paula D. R.; Fernandes, Virginia O.; Akhtar, Hussain; Negrato, Carlos Antonio ; Malmegrim, Kelen Cristina Ribeiro ; Moraes, Daniela Aparecida; Dias, Juliana B. E.; Simões, Belinda Pinto ; Gomes, Marilia Brito ; Rodrigues, Maria Carolina de Oliveira
Source: Frontiers in Endocrinology. Unidade: FMRP
Subjects: CÉLULAS ESTROMAIS, DIABETES MELLITUS, GLICEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABOIA, Jaquellyne G. Penaforte et al. Microvascular complications in type 1 diabetes: a comparative analysis of patients treated with autologous nonmyeloablative hematopoietic stem-cell transplantation and conventional medical therapy. Frontiers in Endocrinology, v. 8, 2017Tradução . . Disponível em: https://doi.org/10.3389/fendo.2017.00331. Acesso em: 28 abr. 2024.
APA
Saboia, J. G. P., Montenegro, R. M., Couri, C. E., Batista, L. A., Montenegro, A. P. D. R., Fernandes, V. O., et al. (2017). Microvascular complications in type 1 diabetes: a comparative analysis of patients treated with autologous nonmyeloablative hematopoietic stem-cell transplantation and conventional medical therapy. Frontiers in Endocrinology, 8. doi:10.3389/fendo.2017.00331
NLM
Saboia JGP, Montenegro RM, Couri CE, Batista LA, Montenegro APDR, Fernandes VO, Akhtar H, Negrato CA, Malmegrim KCR, Moraes DA, Dias JBE, Simões BP, Gomes MB, Rodrigues MC de O. Microvascular complications in type 1 diabetes: a comparative analysis of patients treated with autologous nonmyeloablative hematopoietic stem-cell transplantation and conventional medical therapy [Internet]. Frontiers in Endocrinology. 2017 ; 8[citado 2024 abr. 28 ] Available from: https://doi.org/10.3389/fendo.2017.00331
Vancouver
Saboia JGP, Montenegro RM, Couri CE, Batista LA, Montenegro APDR, Fernandes VO, Akhtar H, Negrato CA, Malmegrim KCR, Moraes DA, Dias JBE, Simões BP, Gomes MB, Rodrigues MC de O. Microvascular complications in type 1 diabetes: a comparative analysis of patients treated with autologous nonmyeloablative hematopoietic stem-cell transplantation and conventional medical therapy [Internet]. Frontiers in Endocrinology. 2017 ; 8[citado 2024 abr. 28 ] Available from: https://doi.org/10.3389/fendo.2017.00331
Artigo de periodico
Immunological balance is associated with clinical outcome after autologous hematopoietic stem cell transplantation in type 1 diabetes (2017)
Malmegrim, Kelen Cristina Ribeiro; Azevedo, Júlia Teixeira Cottas de; Arruda, Lucas Coelho Marliére; Abreu, Joana R. F.; Couri, Carlos Eduardo Barra; Oliveira, Gislane Lelis Vilela de; Palma, Patricia Vianna Bonini; Scortegagna, Gabriela Trentin; Stracieri, Ana Beatriz Pereira Lima; Moraes, Daniela A.; Dias, Juliana Bernardes Elias; Pieroni, Fabiano; Cunha, Renato; Guilherme, Luiza; Santos, Nathália M.; Foss, Milton Cesar; Covas, Dimas Tadeu; Burt, Richard K.; Simões, Belinda Pinto; Voltarelli, Júlio César; Roep, Bart O.; Rodrigues, Maria Carolina de Oliveira
Source: Frontiers in Immunology. Unidade: FMRP
Subjects: CÉLULAS-TRONCO, DIABETES MELLITUS, IMUNOLOGIA, INSULINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALMEGRIM, Kelen Cristina Ribeiro et al. Immunological balance is associated with clinical outcome after autologous hematopoietic stem cell transplantation in type 1 diabetes. Frontiers in Immunology, v. 8, 2017Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2017.00167. Acesso em: 28 abr. 2024.
APA
Malmegrim, K. C. R., Azevedo, J. T. C. de, Arruda, L. C. M., Abreu, J. R. F., Couri, C. E. B., Oliveira, G. L. V. de, et al. (2017). Immunological balance is associated with clinical outcome after autologous hematopoietic stem cell transplantation in type 1 diabetes. Frontiers in Immunology, 8. doi:10.3389/fimmu.2017.00167
NLM
Malmegrim KCR, Azevedo JTC de, Arruda LCM, Abreu JRF, Couri CEB, Oliveira GLV de, Palma PVB, Scortegagna GT, Stracieri ABPL, Moraes DA, Dias JBE, Pieroni F, Cunha R, Guilherme L, Santos NM, Foss MC, Covas DT, Burt RK, Simões BP, Voltarelli JC, Roep BO, Rodrigues MC de O. Immunological balance is associated with clinical outcome after autologous hematopoietic stem cell transplantation in type 1 diabetes [Internet]. Frontiers in Immunology. 2017 ; 8[citado 2024 abr. 28 ] Available from: https://doi.org/10.3389/fimmu.2017.00167
Vancouver
Malmegrim KCR, Azevedo JTC de, Arruda LCM, Abreu JRF, Couri CEB, Oliveira GLV de, Palma PVB, Scortegagna GT, Stracieri ABPL, Moraes DA, Dias JBE, Pieroni F, Cunha R, Guilherme L, Santos NM, Foss MC, Covas DT, Burt RK, Simões BP, Voltarelli JC, Roep BO, Rodrigues MC de O. Immunological balance is associated with clinical outcome after autologous hematopoietic stem cell transplantation in type 1 diabetes [Internet]. Frontiers in Immunology. 2017 ; 8[citado 2024 abr. 28 ] Available from: https://doi.org/10.3389/fimmu.2017.00167
Artigo de periodico
Xenogeneic mesenchymal stromal cells improve wound healing and modulate the immune response in an extensive burn model (2016)
Caliari-Oliveira, Carolina; Yaochite, Juliana Navarro Ueda; Ramalho, Leandra Naíra Zambelli; Palma, Patrícia Vianna Bonini; Carlos, Daniela; Cunha, Fernando de Queiroz; Souza, Daurea Abadia de; Frade, Marco Andrey Cipriani; Covas, Dimas Tadeu; Malmegrim, Kelen Cristina Ribeiro; Oliveira, Maria Carolina; Voltarelli, Julio Cesar
Source: Cell Transplantation. Unidade: FMRP
Subjects: QUEIMADURAS, CÉLULAS-TRONCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CALIARI-OLIVEIRA, Carolina et al. Xenogeneic mesenchymal stromal cells improve wound healing and modulate the immune response in an extensive burn model. Cell Transplantation, v. 25, n. 2, p. 201-215, 2016Tradução . . Disponível em: https://doi.org/10.3727/096368915X688128. Acesso em: 28 abr. 2024.
APA
Caliari-Oliveira, C., Yaochite, J. N. U., Ramalho, L. N. Z., Palma, P. V. B., Carlos, D., Cunha, F. de Q., et al. (2016). Xenogeneic mesenchymal stromal cells improve wound healing and modulate the immune response in an extensive burn model. Cell Transplantation, 25( 2), 201-215. doi:10.3727/096368915X688128
NLM
Caliari-Oliveira C, Yaochite JNU, Ramalho LNZ, Palma PVB, Carlos D, Cunha F de Q, Souza DA de, Frade MAC, Covas DT, Malmegrim KCR, Oliveira MC, Voltarelli JC. Xenogeneic mesenchymal stromal cells improve wound healing and modulate the immune response in an extensive burn model [Internet]. Cell Transplantation. 2016 ; 25( 2): 201-215.[citado 2024 abr. 28 ] Available from: https://doi.org/10.3727/096368915X688128
Vancouver
Caliari-Oliveira C, Yaochite JNU, Ramalho LNZ, Palma PVB, Carlos D, Cunha F de Q, Souza DA de, Frade MAC, Covas DT, Malmegrim KCR, Oliveira MC, Voltarelli JC. Xenogeneic mesenchymal stromal cells improve wound healing and modulate the immune response in an extensive burn model [Internet]. Cell Transplantation. 2016 ; 25( 2): 201-215.[citado 2024 abr. 28 ] Available from: https://doi.org/10.3727/096368915X688128
Artigo de periodico
Plasma eicosanoid profiles determined by high-performance liquid chromatography coupled with tandem mass spectrometry in stimulated peripheral blood from healthy individuals and sickle cell anemia patients in treatment (2016)
Galvão, Alyne Fávero; Petta, Tânia; Flamand, Nicolas; Bollela, Valdes Roberto; Silva, Célio Lopes; Jarduli, Luciana Ribeiro; Malmegrim, Kelen Cristina Ribeiro; Simões, Belinda Pinto; Moraes, Luiz Alberto Beraldo de; Faccioli, Lucia Helena
Source: Analytical and Bioanalytical Chemistry. Unidades: FMRP, FFCLRP, FCFRP
Subjects: ANEMIA FALCIFORME, TRANSFUSÃO DE SANGUE, CROMATOGRAFIA LÍQUIDA DE ALTA PRESSÃO, EICOSANOIDES, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GALVÃO, Alyne Fávero et al. Plasma eicosanoid profiles determined by high-performance liquid chromatography coupled with tandem mass spectrometry in stimulated peripheral blood from healthy individuals and sickle cell anemia patients in treatment. Analytical and Bioanalytical Chemistry, v. 408, n. 13, p. 3613-3623, 2016Tradução . . Disponível em: https://doi.org/10.1007/s00216-016-9445-8. Acesso em: 28 abr. 2024.
APA
Galvão, A. F., Petta, T., Flamand, N., Bollela, V. R., Silva, C. L., Jarduli, L. R., et al. (2016). Plasma eicosanoid profiles determined by high-performance liquid chromatography coupled with tandem mass spectrometry in stimulated peripheral blood from healthy individuals and sickle cell anemia patients in treatment. Analytical and Bioanalytical Chemistry, 408( 13), 3613-3623. doi:10.1007/s00216-016-9445-8
NLM
Galvão AF, Petta T, Flamand N, Bollela VR, Silva CL, Jarduli LR, Malmegrim KCR, Simões BP, Moraes LAB de, Faccioli LH. Plasma eicosanoid profiles determined by high-performance liquid chromatography coupled with tandem mass spectrometry in stimulated peripheral blood from healthy individuals and sickle cell anemia patients in treatment [Internet]. Analytical and Bioanalytical Chemistry. 2016 ; 408( 13): 3613-3623.[citado 2024 abr. 28 ] Available from: https://doi.org/10.1007/s00216-016-9445-8
Vancouver
Galvão AF, Petta T, Flamand N, Bollela VR, Silva CL, Jarduli LR, Malmegrim KCR, Simões BP, Moraes LAB de, Faccioli LH. Plasma eicosanoid profiles determined by high-performance liquid chromatography coupled with tandem mass spectrometry in stimulated peripheral blood from healthy individuals and sickle cell anemia patients in treatment [Internet]. Analytical and Bioanalytical Chemistry. 2016 ; 408( 13): 3613-3623.[citado 2024 abr. 28 ] Available from: https://doi.org/10.1007/s00216-016-9445-8
Artigo de periodico
Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties (2016)
Yaochite, Juliana Navarro Ueda; Lima, Kalil Willian Alves de; Callari-Oliveira, Carolina; Palma, Patricia Vianna Bonini; Couri, Carlos Eduardo Barra; Simões, Belinda Pinto; Covas, Dimas Tadeu; Voltarelli, Júlio César; Oliveira, Maria Carolina; Donadi, Eduardo Antônio; Malmegrim, Kelen Cristina Ribeiro
Source: Stem Cell Research and Therapy. Unidade: FMRP
Subjects: DIABETES MELLITUS, CITOCINAS, DIFERENCIAÇÃO CELULAR, PÂNCREAS, BAÇO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YAOCHITE, Juliana Navarro Ueda et al. Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties. Stem Cell Research and Therapy, v. 7, 2016Tradução . . Disponível em: https://doi.org/10.1186/s13287-015-0261-4. Acesso em: 28 abr. 2024.
APA
Yaochite, J. N. U., Lima, K. W. A. de, Callari-Oliveira, C., Palma, P. V. B., Couri, C. E. B., Simões, B. P., et al. (2016). Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties. Stem Cell Research and Therapy, 7. doi:10.1186/s13287-015-0261-4
NLM
Yaochite JNU, Lima KWA de, Callari-Oliveira C, Palma PVB, Couri CEB, Simões BP, Covas DT, Voltarelli JC, Oliveira MC, Donadi EA, Malmegrim KCR. Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties [Internet]. Stem Cell Research and Therapy. 2016 ; 7[citado 2024 abr. 28 ] Available from: https://doi.org/10.1186/s13287-015-0261-4
Vancouver
Yaochite JNU, Lima KWA de, Callari-Oliveira C, Palma PVB, Couri CEB, Simões BP, Covas DT, Voltarelli JC, Oliveira MC, Donadi EA, Malmegrim KCR. Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties [Internet]. Stem Cell Research and Therapy. 2016 ; 7[citado 2024 abr. 28 ] Available from: https://doi.org/10.1186/s13287-015-0261-4
Artigo de periodico
Cultured human adipose tissue pericytes and mesenchymal stromal cells display a very similar gene expression profile (2015)
Meirelles, Lindolfo da Silva; Malta, Tathiane Maistro; Wagatsuma, Virgínia Mara de Deus; Palma, Patrícia Viana Bonini; Araújo, Amélia Goes; Malmegrim, Kelen Cristina Ribeiro; Oliveira, Fábio Morato de; Panepucci, Rodrigo Alexandre; Silva Júnior, Wilson Araújo da; Covas, Dimas Tadeu
Source: Stem Cells and Development. Unidades: FMRP, FCFRP
Subjects: CÉLULAS-TRONCO, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEIRELLES, Lindolfo da Silva et al. Cultured human adipose tissue pericytes and mesenchymal stromal cells display a very similar gene expression profile. Stem Cells and Development, v. 24, n. 23, p. 2822-2840, 2015Tradução . . Disponível em: https://doi.org/10.1089/scd.2015.0153. Acesso em: 28 abr. 2024.
APA
Meirelles, L. da S., Malta, T. M., Wagatsuma, V. M. de D., Palma, P. V. B., Araújo, A. G., Malmegrim, K. C. R., et al. (2015). Cultured human adipose tissue pericytes and mesenchymal stromal cells display a very similar gene expression profile. Stem Cells and Development, 24( 23), 2822-2840. doi:10.1089/scd.2015.0153
NLM
Meirelles L da S, Malta TM, Wagatsuma VM de D, Palma PVB, Araújo AG, Malmegrim KCR, Oliveira FM de, Panepucci RA, Silva Júnior WA da, Covas DT. Cultured human adipose tissue pericytes and mesenchymal stromal cells display a very similar gene expression profile [Internet]. Stem Cells and Development. 2015 ; 24( 23): 2822-2840.[citado 2024 abr. 28 ] Available from: https://doi.org/10.1089/scd.2015.0153
Vancouver
Meirelles L da S, Malta TM, Wagatsuma VM de D, Palma PVB, Araújo AG, Malmegrim KCR, Oliveira FM de, Panepucci RA, Silva Júnior WA da, Covas DT. Cultured human adipose tissue pericytes and mesenchymal stromal cells display a very similar gene expression profile [Internet]. Stem Cells and Development. 2015 ; 24( 23): 2822-2840.[citado 2024 abr. 28 ] Available from: https://doi.org/10.1089/scd.2015.0153
Artigo de periodico
Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice (2015)
Yaochite, Juliana Navarro Ueda; Caliari-Oliveira, Carolina; Souza, Lucas Eduardo Botelho de; Sbragia Neto, Lourenço; Palma, Patrícia Vianna Bonini; Covas, Dimas Tadeu; Malmegrim, Kelen Cristina Ribeiro; Voltarelli, Júlio César; Donadi, Eduardo Antônio
Source: Stem Cell Research & Therapy. Unidade: FMRP
Subjects: CÉLULAS-TRONCO, TECIDO ADIPOSO, DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YAOCHITE, Juliana Navarro Ueda et al. Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice. Stem Cell Research & Therapy, v. 6, 2015Tradução . . Disponível em: https://doi.org/10.1186/s13287-015-0017-1. Acesso em: 28 abr. 2024.
APA
Yaochite, J. N. U., Caliari-Oliveira, C., Souza, L. E. B. de, Sbragia Neto, L., Palma, P. V. B., Covas, D. T., et al. (2015). Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice. Stem Cell Research & Therapy, 6. doi:10.1186/s13287-015-0017-1
NLM
Yaochite JNU, Caliari-Oliveira C, Souza LEB de, Sbragia Neto L, Palma PVB, Covas DT, Malmegrim KCR, Voltarelli JC, Donadi EA. Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice [Internet]. Stem Cell Research & Therapy. 2015 ; 6[citado 2024 abr. 28 ] Available from: https://doi.org/10.1186/s13287-015-0017-1
Vancouver
Yaochite JNU, Caliari-Oliveira C, Souza LEB de, Sbragia Neto L, Palma PVB, Covas DT, Malmegrim KCR, Voltarelli JC, Donadi EA. Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice [Internet]. Stem Cell Research & Therapy. 2015 ; 6[citado 2024 abr. 28 ] Available from: https://doi.org/10.1186/s13287-015-0017-1

USP Schools

ReP

Filtros

Document Types

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration